天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

ChemicalBook--->CAS DataBase List--->65369-76-8

65369-76-8

65369-76-8 Structure

65369-76-8 Structure
IdentificationMore
[Name]

1-(3-Chlorophenyl)piperazine hydrochloride
[CAS]

65369-76-8
[Synonyms]

1-(3-CHLORO PHENYL)-PIPERAZINE HCL
1-(3-CHLOROPHENYL)PIPERAZINE HYDROCHLORIDE
1-(3-CHLOROPHENYL)PIPERAZINE MONOHYDROCHLORIDE
1-(3-CHLOROPHENYL)PIPERAZINIUM CHLORIDE
1-(M-CHLOROPHENYL) PIPERAZINE HYDROCHLORIDE
LABOTEST-BB LT00159902
M-CPP
M-CPP HYDROCHLORIDE
N-(3-CHLOROPHENYL) PIPERAZINE HYDROCHLORIDE
TIMTEC-BB SBB003261
1-(3-CHLOROPHENYL)PIPERAZINE 2HCL
1-(3-Chlorophenyl)piperazine hydrochloride,97%
N-(3-Chlorophenyl) Piperazine HCl
1-(3-CHLOROPHENYL)-PIPERAZINE HCL (MCLPPB)
1-(3-Chlorophenyl)piperazine hydrochloride
Piperazine, 1-(3-chlorophenyl)-, hydrochloride
1-(3-Chlorophenyl)piperidine/hydrochloric acid,(1:x)
[EINECS(EC#)]

235-976-9
[Molecular Formula]

C10H14Cl2N2
[MDL Number]

MFCD00039032
[Molecular Weight]

233.14
[MOL File]

65369-76-8.mol
Chemical PropertiesBack Directory
[Melting point ]

210-214 °C (dec.)(lit.)
[density ]

1,193g/cm
[refractive index ]

1,598-1,600
[Fp ]

9℃
[storage temp. ]

Store at RT
[solubility ]

methanol: soluble
[form ]

Solid
[color ]

Pale brown
[Detection Methods]

GC,NMR
[Stability:]

Hygroscopic
[CAS DataBase Reference]

65369-76-8(CAS DataBase Reference)
Safety DataBack Directory
[Hazard Codes ]

Xi
[Risk Statements ]

R36/37/38:Irritating to eyes, respiratory system and skin .
[Safety Statements ]

S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice .
S36:Wear suitable protective clothing .
S24/25:Avoid contact with skin and eyes .
[RIDADR ]

UN1230 - class 3 - PG 2 - Methanol, solution
[WGK Germany ]

3
[HazardClass ]

IRRITANT
[HS Code ]

29339900
Material Safety Data Sheet(MSDS)Back Directory
[msds information]

1-(m-Chlorophenyl)piperazine hydrochloride(65369-76-8).msds
Hazard InformationBack Directory
[Chemical Properties]

Off-white solid
[Uses]

Chlorophenyl Piperazine Hydrochloride Salt is a useful intermediate for organic synthesis and other chemical properties. Trazodone impurity.
[General Description]

1-(3-Chlorophenyl)-piperazine, also known as meta-chlorophenylpiperazine or mCPP, is a designer drug analog of aryl-substituted piperazines. A stimulant, serotonin antagonist and reuptake inhibitor (SARU), mCPP can also be detected as a primary urinary metabolite of the antidepressant drug trazadone. This certified solution standard is suitable for use in piperazine testing methods by LC/MS or GC/MS for clinical toxicology, forensic analysis, or urine drug testing applications.
[Biological Activity]

5-HT 2C/2B receptor agonist/partial agonist; displays some activity at 5-HT 2A and 5-HT 1 receptors. pEC 50 values are 7.09, 7.2, 6.65, 5.9 and 6.5 for human recombinant 5-HT 2C , 2B and 2A , bovine 5-HT 1A and rat 5-HT 1B receptors respectively. Suppresses locomotor activity in rats in vivo .
Spectrum DetailBack Directory
[Spectrum Detail]

1-(3-Chlorophenyl)piperazine hydrochloride(65369-76-8)MS
1-(3-Chlorophenyl)piperazine hydrochloride(65369-76-8)1HNMR
1-(3-Chlorophenyl)piperazine hydrochloride(65369-76-8)13CNMR
1-(3-Chlorophenyl)piperazine hydrochloride(65369-76-8)IR1
1-(3-Chlorophenyl)piperazine hydrochloride(65369-76-8)IR2
1-(3-Chlorophenyl)piperazine hydrochloride(65369-76-8)Raman
Tags:65369-76-8 Related Product Information
768-33-2 58479-61-1 110-85-0 119413-54-6 76-83-5 13078-12-1 41202-77-1 38869-46-4 52605-52-4 55827-50-4 57260-67-0 51639-49-7 19794-93-5 119532-26-2 93-55-0 41202-32-8 6640-24-0 76835-17-1

This site uses cookies
This website uses cookies and similar technologies to store and retrieve information about your use of this website. This information helps us to provide, analyse and improve our services, which may include personalised content or advertising. We may share this information with Google and other third parties. This cookies are necessary for our website to work properly . By clicking "Continue" or continuing to browse our site you are agreeing to our and our partners use of cookies.
Accept